vTv Therapeutics shares soar on licensing tie-up with Chinese group Newsoara Biopharma
Newsoara will develop vTv Therapeutics' HPP737 as a new treatment for chronic obstructive pulmonary disease
VTv Therape...
From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment
Continue readingAdvertisement
Advertisement
Advertisement
Advertisement
Advertisement